| 发明名称 |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease |
| 摘要 |
The present invention relates generally to the novel use of incretin compounds (ICs) and amylinomimetic compounds to treat, prevent, or ameliorate a variety of metabolic conditions or diseases. |
| 申请公布号 |
US8389472(B2) |
申请公布日期 |
2013.03.05 |
| 申请号 |
US20060063712 |
申请日期 |
2006.08.21 |
| 申请人 |
BARON ALAIN D.;KIM DENNIS;MAGGS DAVID G.;WINTLE MATTHEW;AMYLIN PHARMACEUTICALS, LLC;ASTRAZENECA PHARMACEUTICALS LP |
发明人 |
BARON ALAIN D.;KIM DENNIS;MAGGS DAVID G.;WINTLE MATTHEW |
| 分类号 |
A61K38/26;A61K38/00;A61K38/16;A61K39/00 |
主分类号 |
A61K38/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
